相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of age and CYP2D6 genetics on exposure of aripiprazole and dehydroaripiprazole in patients using long-acting injectable versus oral formulation: relevance of poor and intermediate metabolizer status
Marit Tveito et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients
Line S. Braten et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Impact of CYP1A2, CYP2C19, and CYP2D6 genotype- and phenoconversion-predicted enzyme activity on clozapine exposure and symptom severity
Dorothea Lesche et al.
PHARMACOGENOMICS JOURNAL (2020)
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia
Stefan Leucht et al.
AMERICAN JOURNAL OF PSYCHIATRY (2020)
Translation of pharmacogenomic drug labels into the clinic. Current problems
Magnus Ingelman-Sundberg
PHARMACOLOGICAL RESEARCH (2020)
The Influence of Combined CYP2D6 and CYP2C19 Genotypes on Venlafaxine and O-Desmethylvenlafaxine Concentrations in a Large Patient Cohort
Marianne K. Kringen et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2020)
Completed suicides of citalopram users-the role of CYP genotypes and adverse drug interactions
Anna-Liina Rahikainen et al.
INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2019)
Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study
John F. Greden et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2019)
Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis
Toshi A. Furukawa et al.
LANCET PSYCHIATRY (2019)
Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study
Marin M. Jukic et al.
LANCET PSYCHIATRY (2019)
Dopamine D2 Receptor Occupancy Estimated From Plasma Concentrations of Four Different Antipsychotics and the Subjective Experience of Physical and Mental Well-Being in Schizophrenia Results From the Randomized NeSSy Trial
Tanja Veselinovic et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2019)
Clinical Implementation of Pharmacogenetic Decision Support Tools for Antidepressant Drug Prescribing
Zane Zeier et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients
Marin M. Jukic et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies
Chiara Fabbri et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2018)
Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utility
Paul Bradley et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2018)
Effects of Cytochrome P450 (CYP) 2C19 Genotypes on Steady-State Plasma Concentrations of Escitalopram and its Desmethyl Metabolite in Japanese Patients With Depression
Shoko Tsuchimine et al.
THERAPEUTIC DRUG MONITORING (2018)
Effects of aripiprazole on pupillometric parameters related to pharmacokinetics and pharmacogenetics after single oral administration to healthy subjects
Dora Koller et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Genetic Determinants of Clozapine-Induced Metabolic Side Effects
Kamini Vasudev et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2017)
Prediction of CYP2D6 phenotype from genotype across world populations
Andrea Gaedigk et al.
GENETICS IN MEDICINE (2017)
Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment
M. M. Jukic et al.
MOLECULAR PSYCHIATRY (2017)
Potential Role of Patients' CYP3A-Status in Clozapine Pharmacokinetics
Katalin Toth et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2017)
Quantification of the steady-state plasma concentrations of clozapine and N-desmethylclozapine in Japanese patients with schizophrenia using a novel HPLC method and the effects of CYPs and ABC transporters polymorphisms
Yumiko Akamine et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2017)
Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects
Y. Zhou et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial
Victor Perez et al.
BMC PSYCHIATRY (2017)
Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients
Sergi Mas et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
Genotype and co-medication dependent CYP2D6 metabolic activity: effects on serum concentrations of aripiprazole, haloperidol, risperidone, paliperidone and zuclopenthixol
Patteet Lisbeth et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations
I. Fricke-Galindo et al.
PHARMACOGENOMICS JOURNAL (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Cytochrome P450 2D6 genotype affects the pharmacokinetics of controlled-release paroxetine in healthy Chinese subjects: comparison of traditional phenotype and activity score systems
Rui Chen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients
Karen van der Weide et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2015)
Impact of Genetic Variability in CYP2D6, CYP3A5, and ABCB1 on Serum Concentrations of Quetiapine and N-desalkylquetiapine in Psychiatric Patients
Gry V. Bakken et al.
THERAPEUTIC DRUG MONITORING (2015)
The influences of CYP2D6 genotypes and drug interactions on the pharmacokinetics of venlafaxine: exploring predictive biomarkers for treatment outcomes
Fen Jiang et al.
PSYCHOPHARMACOLOGY (2015)
Risperidone metabolic ratio as a biomarker of individual CYP2D6 genotype in schizophrenic patients
Buster Mannheimer et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Genetic differences in cytochrome P450 enzymes and antidepressant treatment response
Karen Hodgson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Effect of CYP2D6 on risperidone pharmacokinetics and extrapyramidal symptoms in healthy volunteers: results from a pharmacogenetic clinical trial
Patricia Gasso et al.
PHARMACOGENOMICS (2014)
Effects of Genetic Polymorphisms of CYP2D6, CYP3A5, and ABCB1 on the Steady-State Plasma Concentrations of Aripiprazole and Its Active Metabolite, Dehydroaripiprazole, in Japanese Patients With Schizophrenia
Takeshi Suzuki et al.
THERAPEUTIC DRUG MONITORING (2014)
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
Stefan Leucht et al.
LANCET (2013)
Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function
J. C. Stingl et al.
MOLECULAR PSYCHIATRY (2013)
Relationship between CYP2D6 genotype and haloperidol pharmacokinetics and extrapyramidal symptoms in healthy volunteers
Patricia Gasso et al.
PHARMACOGENOMICS (2013)
Use of pharmacogenetics in bioequivalence studies to reduce sample size: an example with mirtazapine and CYP2D6
N. Gonzalez-Vacarezza et al.
PHARMACOGENOMICS JOURNAL (2013)
The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine
Junichi Azuma et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Effect of the cytochrome P450 2D6*10 allele on risperidone metabolism in Japanese psychiatric patients
Yutaro Suzuki et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2012)
Multicenter Study on the Clinical Effectiveness, Pharmacokinetics, and Pharmacogenetics of Mirtazapine in Depression
Eveline Jaquenoud Sirot et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Pharmacokinetics of Venlafaxine Extended Release 75 mg and Desvenlafaxine 50 mg in Healthy CYP2D6 Extensive and Poor Metabolizers A Randomized, Open-Label, Two-Period, Parallel-Group, Crossover Study
Alice I. Nichols et al.
CLINICAL DRUG INVESTIGATION (2011)
CYP2D6 genotype and smoking influence fluvoxamine steady-state concentration in Japanese psychiatric patients: lessons for genotype-phenotype association study design in translational pharmacogenetics
Yutaro Suzuki et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Effects of the CYP2D6*10 Allele on the Steady-State Plasma Concentrations of Aripiprazole and Its Active Metabolite, Dehydroaripiprazole, in Japanese Patients With Schizophrenia
Takeshi Suzuki et al.
THERAPEUTIC DRUG MONITORING (2011)
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Effects of Cigarette Smoking and Cytochrome P450 2D6 Genotype on Fluvoxamine Concentration in Plasma of Japanese Patients
Yasuhiro Katoh et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2010)
The role of CYP2D6 and ABCB1 pharmacogenetics in drug-na⟨ve patients with first-episode schizophrenia treated with risperidone
Nikolina Jovanovic et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Effect of CYP2D6, CYP3A5, and MDR1 Genetic Polymorphisms on the Pharmacokinetics of Risperidone and Its Active Moiety
Qian Xiang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Effects of CYP2D6 Genotype on the Pharmacokinetics, Pharmacodynamics, and Safety of Risperidone in Healthy Volunteers
Jesus Novalbos et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2010)
Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response
Ming-Hsien Tsai et al.
PHARMACOGENOMICS (2010)
Effect of Cytochrome P450 2D6 Genotype on Maternal Paroxetine Plasma Concentrations during Pregnancy
F. F. Tessa Ververs et al.
CLINICAL PHARMACOKINETICS (2009)
Steady-State Concentrations of Mirtazapine, N-Desmethylmirtazapine, 8-Hydroxymirtazapine and their Enantiomers in Relation to Cytochrome P450 2D6 Genotype, Age and Smoking Behaviour
Anna-Britta Lind et al.
CLINICAL PHARMACOKINETICS (2009)
Effect of smoking and CYP2D6 polymorphisms on the extent of fluvoxamine-alprazolam interaction in patients with psychosomatic disease
Hideyo Sugahara et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Impact of CYP2D6 Genotype on Steady-State Serum Concentrations of Risperidone and 9-Hydroxyrisperidone in Patients Using Long-Acting Injectable Risperidone
Magnhild Hendset et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
Effects of CYP2D6 and CYP3A5 Genotypes on the Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone in Korean Schizophrenic Patients
Rhee-Hun Kang et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
Comparison of the Pharmacokinetics of Venlafaxine Extended Release and Desvenlafaxine in Extensive and Poor Cytochrome P450 2D6 Metabolizers
Sheldon Preskorn et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
ABCB1 and Cytochrome P450 Polymorphisms Clinical Pharmacogenetics of Clozapine
Eveline Jaquenoud Sirot et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: A simulation study
Jan O. Friedrich et al.
BMC MEDICAL RESEARCH METHODOLOGY (2008)
Serum concentrations of venlafaxine and its metabolites O-desmethylvenlafaxine and N-desmethylvenlafaxine in heterozygous carriers of the CYP2D6*3, *4 or *5 allele
M. Hermann et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Serum concentrations of sertraline and N-desmethyl sertraline in relation to CYP2C19 genotype in psychiatric patients
I. Rudberg et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Dose-Dependent Effect of the CYP2D6 Genotype on the Steady-state Fluvoxamine Concentration
Junzo Watanabe et al.
THERAPEUTIC DRUG MONITORING (2008)
A study of genetic (CYP2D6 and ABCB1) and environmental (drug inhibitors and inducers) variables that may influence plasma risperidone levels
J. de Leon et al.
PHARMACOPSYCHIATRY (2007)
Prolactin release in children treated with risperidone - Impact and role of CYP2D6 metabolism
Pieter W. Troost et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Pharmacokinetics of aripiprazole, a new antipsychotic, following oral dosing in healthy adult Japanese volunteers: Influence of CYP2D6 polymorphism
Masanori Kubo et al.
DRUG METABOLISM AND PHARMACOKINETICS (2007)
Sequence-based CYP2D6 genotyping in the Korean population
Soo-Youn Lee et al.
THERAPEUTIC DRUG MONITORING (2006)
Pharmacokinetics and bioequivalence evaluation of risperidone in healthy male subjects with different CYP2D6 genotypes
Hea-Young Cho et al.
ARCHIVES OF PHARMACAL RESEARCH (2006)
Combined effects of itraconazole and CYP2D6*10 genetic polymorphism on the pharmacokinetics and pharmacodynamics of haloperidol in healthy subjects
JY Park et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Cytochrome P450 3A inhibitor itraconazole affects plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients
SM Jung et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation
J de Leon et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Allele-specific change of concentration and functional gene dose for the prediction of steady-state serum concentrations of amitriptyline and nortriptyline in CYP2C19 and CYP2D6 extensive and intermediate metabolizers
W Steimer et al.
CLINICAL CHEMISTRY (2004)
Impact of the CYP2D6 utrarapid metabolizer genotype on mirtazapine pharmacokinetics and adverse events in healthy volunteers
J Kirchheiner et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Effects of dosage and CYP2D6-mutated allele on plasma concentration of paroxetine
K Sawamura et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Polymorphisms in the CYP 2D6 gene: Association with plasma concentrations of fluoxetine and paroxetine
C Charlier et al.
THERAPEUTIC DRUG MONITORING (2003)
Effects of smoking and cytochrome P450 2D6*10 allele on the plasma haloperidol concentration/dose ratio
K Ohara et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
Cytochrome P450 II D6 gene polymorphisms and the neuroleptic-induced extrapyramidal symptoms in Japanese schizophrenic patients
T Inada et al.
PSYCHIATRIC GENETICS (2003)
Effect of CYP2D6 genotypes on the metabolism of haloperidol in a Japanese psychiatric population
T Someya et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Effects of the CYP 2D6 genotype and cigarette smoking on the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients
G Gerstenberg et al.
THERAPEUTIC DRUG MONITORING (2003)
Effects of various CYP2D6 genotypes on the steady-state plasma concentrations of risperidone and its active metabolite, 9-hydroxyrisperidone, in Japanese patients with schizophrenia
K Mihara et al.
THERAPEUTIC DRUG MONITORING (2003)
Effects of CYP2D6 genotypes on plasma concentrations of risperidone and enantiomers of 9-hydroxyrisperidone in Japanese patients with schizophrenia
N Yasui-Furukori et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
CYP2D6*10 alleles do not determine plasma fluvoxamine concentration/dose ratio in Japanese subjects
K Ohara et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6
M Desai et al.
PHARMACOGENOMICS JOURNAL (2003)
The impact of the CYP2D6 polymorphism on haloperidol pharmacoldnetics and on the outcome of haloperidol treatment
J Brockmöller et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
The role of CYP2C19 in amitriptyline N-demethylation in Chinese subjects
ZP Jiang et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
The effect of fluoxetine on the pharmacokinetics and safety of risperidone in psychotic patients
G Bondolfi et al.
PHARMACOPSYCHIATRY (2002)
Risperidone metabolism in relation to CYP2D6*10 allele in Korean schizophrenic patients
HK Roh et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Plasma concentrations of haloperidol are related to CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patients
HK Roh et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Effect of the CYP2C19 oxidation polymorphism on fluoxetine metabolism in Chinese healthy subjects
ZQ Liu et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Concentrations of the enantiomers of fluoxetine and norfluoxetine after multiple doses of fluoxetine in cytochrome P4502D6 poor and extensive metabolizers
CB Eap et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
CYP2D6*10 alleles are not the determinant of the plasma haloperidol concentrations in Asian patients
K Shimoda et al.
THERAPEUTIC DRUG MONITORING (2000)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Relationship of paroxetine disposition to metoprolol metabolic ratio and CΨP2D6*10 genotype of Korean subjects
YR Yoon et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Steady-state plasma levels of nortriptyline and its hydroxylated metabolites in Japanese patients: Impact of CYP2D6 genotype on the hydroxylation of nortriptyline
S Morita et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2000)
The impact of the CYP2D6 and CYP2C19 genotypes on venlafaxine pharmacokinetics in a Japanese population
T Fukuda et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2000)
分享论文
